登录 注册 会员服务 联系我们

Gemcitabine causes telomere attrition by stabilizing TRF2

  • Published:2012-12 Issue:18 Volume:48 Page:3465-3474
  • ISSN:0959-8049
  • Container-title:European Journal of Cancer
  • language:en
  • Short-container-title:European Journal of Cancer

Author:

Su Chih-Hao,Chu Wei-Chih,Lan Keng-Hsin,Li Chung-Pin,Chao Yee,Lin Han-Chieh,Lee Shou-Dong,Tsai Ying-Chieh,Lee Wei-Ping

Funder

National Science Council

Taipei Veterans General Hospital

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Gemcitabine and targeted therapy in metastatic breast cancer;Qu;Semin Oncol,2002

2. Gemcitabine induction chemotherapy in non-small cell lung cancer;Depierre;Semin Oncol,2002

3. Present and future treatment of pancreatic cancer;Heinemann;Semin Oncol,2002

4. Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies;Fleming;Am J Clin Oncol,2000

5. Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity;Rauchwerger;Cancer Res,2000

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3